Late infantile CACH syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157716OMIM:603896E75.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Late infantile CACH syndrome (Childhood Ataxia with Central Nervous System Hypomyelination), also known as late infantile Vanishing White Matter disease (VWM), is a rare inherited leukoencephalopathy caused by mutations in genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1-EIF2B5). The late infantile form represents one of the more severe phenotypic variants of VWM disease, with onset typically occurring between ages 1 and 2 years. The disease primarily affects the central nervous system, specifically the white matter of the brain, which progressively deteriorates and is replaced by fluid-filled cavities — hence the name 'vanishing white matter.' Key clinical features of the late infantile form include progressive cerebellar ataxia (loss of coordination), spasticity, cognitive decline, and eventual loss of motor and intellectual abilities. A hallmark of VWM disease is that neurological deterioration can be triggered or dramatically worsened by episodes of physiological stress such as febrile infections, minor head trauma, or acute fright. Seizures may also occur. Brain MRI characteristically shows diffuse white matter abnormalities with progressive rarefaction and cystic degeneration. Ovarian failure (ovarioleukodystrophy) can be an associated feature in females, though this is more commonly noted in later-onset forms. There is currently no cure or disease-modifying treatment for late infantile CACH syndrome. Management is supportive and symptomatic, focusing on physical therapy, prevention and careful management of febrile episodes and infections, seizure control when needed, and nutritional support. Avoidance of physiological stressors that can precipitate neurological crises is a critical aspect of care. The prognosis for the late infantile form is generally poor, with progressive neurological decline leading to severe disability. Research into potential therapies, including gene therapy approaches, is ongoing.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Late infantile CACH syndrome.

View clinical trials →

No actively recruiting trials found for Late infantile CACH syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Late infantile CACH syndrome community →

No specialists are currently listed for Late infantile CACH syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Late infantile CACH syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Late infantile CACH syndromeForum →

No community posts yet. Be the first to share your experience with Late infantile CACH syndrome.

Start the conversation →

Latest news about Late infantile CACH syndrome

No recent news articles for Late infantile CACH syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Late infantile CACH syndrome

What is Late infantile CACH syndrome?

Late infantile CACH syndrome (Childhood Ataxia with Central Nervous System Hypomyelination), also known as late infantile Vanishing White Matter disease (VWM), is a rare inherited leukoencephalopathy caused by mutations in genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1-EIF2B5). The late infantile form represents one of the more severe phenotypic variants of VWM disease, with onset typically occurring between ages 1 and 2 years. The disease primarily affects the central nervous system, specifically the white matter of the brain, which progressively deteriorat

How is Late infantile CACH syndrome inherited?

Late infantile CACH syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Late infantile CACH syndrome typically begin?

Typical onset of Late infantile CACH syndrome is infantile. Age of onset can vary across affected individuals.